A prospective, randomized study comparing coiling vs. Surefire Infusion in Y90.
Now available in two different sizes, the next generation Surefire Infusion System maximizes targeted delivery without reflux.
Improved trackability. Enhanced delivery. Optimized torque.
J. D. Louie et al., Stanford University Medical Center, “In chemoembolization patients, completion C-arm CT imaging suggested a pattern of increased microsphere tumor penetration and contrast retention”, March 2012.
Study shows Surefire Infusion System achieving 99.9% embolization efficiency versus 72% in a standard microcatheter, Dec. 2012.